Uncertainties in spatial modeling studies of schistosomiasis (SCH) are relevant for the reliable identification of at-risk populations. Ecological fallacy occurs when ecological or group-level analyses, such as spatial aggregations at a specific administrative level, are carried out for an individual-level inference. This could lead to the unreliable identification of at-risk populations, and consequently to fallacies in the drugs’ allocation strategies and their cost-effectiveness. A specific form of ecological fallacy is pure specification bias. The present research aims to quantify its effect on the parameter estimates of various environmental covariates used as drivers for SCH infection. This is done by (i) using a spatial convolution model that removes pure specification bias, (ii) estimating group and individual-level covariate regression parameters, and (iii) quantifying the difference between the parameter estimates and the predicted disease outcomes from the convolution and ecological models. We modeled the prevalence of Schistosoma japonicum using group-level health outcome data, and city-level environmental data as a proxy for individual-level exposure. We included environmental data such as water and vegetation indexes, distance to water bodies, day and night land surface temperature, and elevation. We estimated and compared the convolution and ecological model parameter estimates using Bayesian statistics. Covariate parameter estimates from the convolution and ecological models differed between 0.03 for the nearest distance to water bodies (NDWB), and 0.28 for the normalized difference water index (NDWI). The convolution model presented lower uncertainties in most of the parameter estimates, except for NDWB. High differences in uncertainty were found in night land surface temperature (0.23) and elevation (0.13). No significant differences were found between the predicted values and their uncertainties from both models. The proposed convolution model is able to correct for a pure specification bias by presenting less uncertain parameter estimates. It shows a good predictive performance for the mean prevalence values and for a positive number of infected people. Further research is needed to better understand the spatial extent and support of analysis to reliably explore the role of environmental variables.

Spatial modelling studies of schistosomiasis (SCH) are now commonplace. Covariate values are commonly extracted at survey locations, where infection does not always take place, resulting in an unknown positional exposure mismatch. The present research aims to: (i) describe the nature of the positional exposure mismatch in modelling SCH helminth infections; (ii) delineate exposure areas to correct for such positional mismatch; and (iii) validate exposure areas using human positive cases. To delineate exposure areas to Schistosoma japonicum, a spatial Bayesian network (sBN) was constructed. It uses data on exposure risk factors such as: potential sites for snails’ accessibility, geographical distribution of snail infection rate, and cost of the community to access nearby water bodies. Prior and conditional probabilities were obtained from the literature and inserted as weights based on their relative contribution to exposure; these probabilities were then used to calculate joint probabilities of exposure within the sBN. High values of probability of S. japonicum exposure correspond to polygons where snails could potentially be present, for instance in wet soils and areas with low slopes, but also where people can easily access water bodies. Low correlation (R2 = 0.3) was found between the percentage of human cases and the delineated probabilities of exposure when validation buffers are generated over the human cases. The utility of a probabilistic method for the identification of exposure areas for S. japonicum, with wider application for other water-borne infections, was demonstrated. From a public health perspective, the schistosomiasis exposure sBN developed in this study could be used to guide local schistosomiasis control teams to specific potential areas of exposure, and improve efficiency of mass drug administration campaigns in places where people are likely to be exposed to the infection.